BEE-L Archives

Informed Discussion of Beekeeping Issues and Bee Biology

BEE-L@COMMUNITY.LSOFT.COM

Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Aaron Morris <[log in to unmask]>
Reply To:
Discussion of Bee Biology <[log in to unmask]>
Date:
Mon, 11 Dec 1995 12:14:10 EST
Content-Type:
text/plain
Parts/Attachments:
text/plain (106 lines)
   Taken  fron  the Internet is an excerpt from a September '92
   New Zealand beekeeping newsletter:
 
                   MANUKA CLINICAL TRIALS SOON
 
   Another very interesting presentation at this year's confer-
   ence seminar was made by Dr. Peter Molan of Waikato  Univer-
   sity.  All our readers probably already know about Dr. Molan
   and  his team and the fantastic work they are doing investi-
   gating the antibiotic properties of manuka and other honeys.
   The seminar gave Dr. Molan the opportunity to summarize both
   his work and the substantial scientific  literature  on  the
   medicinal properties of honey.
 
   Honey  has long been used as a wound dressing, and according
   to Dr.  Molan it is probably the perfect substance for  such
   a use.  Not only is it antibiotic (killing almost all bacte-
   ria),  it also keeps the wound from dehydrating.  Almost all
   other wound dressings either keep the  wound  dry  (avoiding
   infection,  but leading to scarring), or moist (avoiding the
   severe effects of dehydration, but making a great medium for
   bacteria to grow).
 
   Honey is also better than man-made antibiotics because  such
   antibiotics actually slow down the rate of cell growth.  The
   hygroscopic  (moisture-attracting)  nature  of honey, on the
   other hand, actually pulls body fluids and nutrients to  the
   wound surface where they help speed skin growth and healing.
 
   According  to  Dr. Molan, honey has got everything going for
   it except the acceptance of the medical fraternity.  But the
   recent discoveries about a second  antibiotic  substance  in
   manuka may help to change all that.
 
   All  honey  gives off hydrogen peroxide, a known antibiotic.
   The hydrogen peroxide is produced when the glucose in  honey
   reacts  with oxygen.   The problem with hydrogen peroxide as
   an antibiotic, however, is that in large  concentrations  it
   breaks  down  in the presence of a common enzyme (catalase),
   producing the characteristic fizz we see when we put it on a
   cut.  Honey, because it produces hydrogen  peroxide  slowly,
   at  a low level, doesn't loose it's effectiveness.  Provided
   honey is kept away from light, the enzyme which breaks  down
   the hydrogen peroxide won't even activate.
 
   Dr.  Molan  and his students tested the hydrogen peroxide in
   honey on a range of bacteria and as a  control  removed  the
   hydrogen  peroxide  with catalase.  That's when they discov-
   ered the second antibacterial property in manuka.  While not
   present in all samples of manuka, some samples showed a high
   level of non-peroxide inhibition over a whole range of  bac-
   teria, even at honey dilutions of as low as 1.8%.
 
   The  exciting  thing about the manuka discovery is that this
   non-peroxide antibiotic substance works against even  highly
   resistant  bacteria such as the MSRA bacteria which is gain-
   ing a reputation for closing down hospital wards.  According
   to Dr. Molan, doctors may soon be looking back at  the  last
   20  years as the golden age of antibiotics.  In the near fu-
   ture we may have a host of bacteria resistant  to  synthetic
   antibiotics,  and the need for naturally occurring antibiot-
   ics like the one found in bioactive manuka will be all  that
   more important.
 
   Manuka  has  been  shown to be effective against Helicobater
   pylori, which is now thought to be the major cause of  stom-
   ach  ulcers.    And this is where the honey is finally to be
   tested in a clinical trial.  A large number of patients will
   be given 1 tablespoon of bioactive manuka or  another  honey
   before meal times, five times a day.  The patients will then
   be  examined  for  the reduction in H. pylori bacteria.  The
   trials are set to begin around New Zealand  once  the  Otago
   University  Hospital  ethics  committee  approves the trial.
   Theztrial will hopefully be funded by a grant from the Honey
   Industry Trust Fund.
 
                      BUGLOSS SAMPLES SOUGHT
 
   Dr. Molan mentioned that the one  honey  other  than  manuka
   that  might  have  the  non-peroxide bioactive ingredient is
   vipers bugloss, also known  blue  borage  (Echium  vulgare).
   The  plant grows in many parts of the country, and is an im-
   portant honey producer in parts of  Central  Otago  and  the
   MacKenzie Country.
 
   The  only problem is that Dr. Molan has only ever tested one
   sample (it was positive), and despite all  his  efforts  has
   been  unable  to get any more.  Now there's bound to be more
   samples of borage honey kicking around the South Island, es-
   pecially after this year's big honey crop,  so  if  you  can
   supply Dr. Molan with a sample, please help him out.  Send a
   50  gm sample, together with as much information as possible
   on where the honey was produced, to Dr. Peter Molan, Depart-
   ment of Biological Sciences, University of Waikato,  Private
   Bag 3105, HAMILTON, ph (07) 856 2889
 
   And  by the way, a lot of people don't know that Dr. Molan's
   real job actually involves  teaching,  supervising  graduate
   students,  and  working with the dairy industry.  Believe it
   or not, his work on manuka honey is just a side-line  inter-
   est, and he hasn't received any government research funds to
   carry  out  the work.  Our whole industry should be thankful
   for the interest and enthusiasm he has shown toward our main
   beekeeping product.  Good on ya, Peter!  Keep  up  the  good
   work!

ATOM RSS1 RSS2